Roles of Growth Factors on Corneal Morphogenesis
生长因子对角膜形态发生的作用
基本信息
- 批准号:8383107
- 负责人:
- 金额:$ 43.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAblationAccountingActivating Transcription Factor 2Adenovirus VectorAdultAllelesAnimal ExperimentationAnimalsAntibodiesBasement membraneBindingBromodeoxyuridineCaliberCell DeathCell ProliferationCell physiologyCollaborationsComplexCorneaCorneal DiseasesCorneal InjuryDNA Double Strand BreakDataDebridementDimerizationDominant-Negative MutationDoxycyclineEpithelial Cell ProliferationEpitheliumEyeFamilyFluoresceinGene DeletionGenesGeneticGrowth FactorHealedHomeostasisHourImmunohistochemistryImmunoprecipitationIn VitroInjuryIntegrinsIntracellular translocationLuciferasesMAP Kinase GeneMAPK8 geneMeasuresMediatingMolecularMolecular BiologyMorphogenesisMusPathway interactionsPatternPhasePhosphorylationPlayProtein BiosynthesisProteinsReceptor SignalingReporterReverse Transcriptase Polymerase Chain ReactionRoleSP600125Signal PathwaySignal TransductionStaining methodStainsStressTetanus Helper PeptideTranscription Factor AP-1Transforming Growth FactorsTransgenesTumor Suppressor ProteinsVariantVirusVisionWestern BlottingWild Type MouseWound Healingbasecell motilitycorneal epitheliumdesigneffective therapyfeedinghealingin vivoinhibitor/antagonistinjuredmembermigrationmouse modelmutantneutralizing antibodyoverexpressionreceptorrepairedresearch studyrestorationsmall hairpin RNAtherapy designtime intervaltranscription factor
项目摘要
Kao, Winston W.-Y.
Transforming growth factor ¿ (TGF-¿) has a pivotal role in corneal wound healing. Previous studies revealed
that activation of p38MAPK and Smad signaling pathway have distinct roles in mediating TGF-¿ signaling of
corneal epithelium debridement and keratectomy, respectively. Such differences can be explained by the fact
that healing epithelium of debridement migrates on basement membrane, whereas that of keratectomy
migrates on collagenous matrix of denuded stroma, resulting in distinct integrin expression patterns in
migrating epithelium within 1 hour of injuries. Thus, we hypothesize that interaction of different integrins with
TGF-¿ receptors accounts for the difference in TGF-¿ signaling pathways, i.e., activation of p38MAPK in
epithelium debridement and Smads cascades in keratectomy (Hypothesis 1). It has also been found that
suppression of cell proliferation and activation of Activating Transcription Factor 2 (ATF2) are independent of
TGF-¿ signaling following epithelium debridement. Thus, the activation of ATF2 by an alternative pathway,
i.e., JNK, and its subsequent formation of Activating Protein-1 transcription factor (AP-1) complex plays a key
role in the suppression of epithelial cell proliferation in the early healing phase of corneal injury (Hypotheisis
2). Specific Aim 1 will identify and characterize roles of integrins in TGF-¿ signaling pathways during the
healing of corneal epithelium debridement and keratectomy using tritransgenic Cre-LoxP mouse models, i.e.,
Krt12rtTA/rtTA/tet-O-Cre/Tbr2f/f and Krt12rtTA/rtTA/tet-O-Cre/Smad4f/f in which floxed Tbr2 and Smad4 genes are
ablated specifically in corneal epithelium upon doxycycline induction so that one can determine potential
variations in signaling pathways in the absence and presence of Tbr2 and Smad4 (Aim 1A), to examine
roles of integrins in mediating TGF-¿ receptor signaling (Aim 1B) and to examine efficacy of p38MAPK¿ and
Smad7 on modulation of cell migration and proliferation during wound healing (Aim 1C). Specific Aim 2 will
elucidate roles of ATF2 and AP-1 in suppression of cell proliferation during corneal wound healing by
identification of ATF2 and/or AP-1 complexes in healing epithelium of corneal epithelium debridement and
keratectomy using immunoprecipitation and western blot analysis (Aim 2A), determine involvement of ATF2
in suppression of cell proliferation during healing of epithelium debridement by overexpression of dominant
negative ATF2 and ¿N-ATF2 mutant proteins (Aim 2B), and to determine effects of JNK and p38MAPK
inhibitors on activation of ATF2 during corneal wound healing (Aim2C).
These experiments will yield useful information for restoration of normal vision by intervening TBR2 and
ATF2 signaling pathways of injured corneas.
温斯顿·高,w - y。
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sonic hedgehog expression and role in healing corneal epithelium
- DOI:10.1167/iovs.04-0001
- 发表时间:2004-08-01
- 期刊:
- 影响因子:4.4
- 作者:Saika, S;Muragaki, Y;Kao, WWY
- 通讯作者:Kao, WWY
Clinical and histopathological features and immunoreactivity of human choroidal and ciliary melanomas as prognostic factors for metastasis and death.
人类脉络膜和睫状体黑色素瘤的临床和组织病理学特征以及免疫反应性作为转移和死亡的预后因素。
- DOI:10.1007/s00417-011-1769-7
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Simões,CamilaC;Call,MindyK;Corrêa,ZéliaM;Spaulding,AbbotG;Augsburger,JamesJ
- 通讯作者:Augsburger,JamesJ
Repressed Wnt Signaling Accelerates the Aging Process in Mouse Eyes.
抑制 Wnt 信号会加速小鼠眼睛的衰老过程。
- DOI:10.1155/2019/7604396
- 发表时间:2019
- 期刊:
- 影响因子:1.9
- 作者:Zhang,Yujin;Jeffrey,Joseph;Dong,Fei;Zhang,Jianhua;Kao,WinstonW-Y;Liu,Chia-Yang;Yuan,Yong
- 通讯作者:Yuan,Yong
Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice
腺病毒基因转染骨形态发生蛋白7对小鼠角膜碱损伤模型的治疗作用
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Saika S;et al.
- 通讯作者:et al.
Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity.
间充质干细胞治疗先天性和后天性角膜混浊的疗效。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:2.2
- 作者:Call,Mindy;Elzarka,Mohamed;Kunesh,Mary;Hura,Nanki;Birk,DavidE;Kao,WinstonW
- 通讯作者:Kao,WinstonW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WINSTON W KAO其他文献
WINSTON W KAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WINSTON W KAO', 18)}}的其他基金
Gene Therapy of Corneal Dystrophy: Lysosomal Storage Diseases
角膜营养不良的基因治疗:溶酶体贮积病
- 批准号:
10203999 - 财政年份:2019
- 资助金额:
$ 43.65万 - 项目类别:
Gene Therapy of Corneal Dystrophy: Lysosomal Storage Diseases
角膜营养不良的基因治疗:溶酶体贮积病
- 批准号:
10018871 - 财政年份:2019
- 资助金额:
$ 43.65万 - 项目类别:
2014 Cornea, Biology & Pathobiology Gordon Research Conference Gordon Research Se
2014 角膜,生物学
- 批准号:
8641527 - 财政年份:2014
- 资助金额:
$ 43.65万 - 项目类别:
Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells
脐带间充质干细胞治疗角膜疾病
- 批准号:
8531948 - 财政年份:2011
- 资助金额:
$ 43.65万 - 项目类别:
Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells
脐带间充质干细胞治疗角膜疾病
- 批准号:
8328680 - 财政年份:2011
- 资助金额:
$ 43.65万 - 项目类别:
Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells
脐带间充质干细胞治疗角膜疾病
- 批准号:
8536477 - 财政年份:2011
- 资助金额:
$ 43.65万 - 项目类别:
Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells
脐带间充质干细胞治疗角膜疾病
- 批准号:
8159876 - 财政年份:2011
- 资助金额:
$ 43.65万 - 项目类别:
Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells
脐带间充质干细胞治疗角膜疾病
- 批准号:
8722564 - 财政年份:2011
- 资助金额:
$ 43.65万 - 项目类别:
Structure/Function Relationship of The Lumican Gene
Lumican基因的结构/功能关系
- 批准号:
7486855 - 财政年份:2006
- 资助金额:
$ 43.65万 - 项目类别:
Structure/Function Relationship of The Lumican Gene
Lumican基因的结构/功能关系
- 批准号:
7677302 - 财政年份:2006
- 资助金额:
$ 43.65万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 43.65万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 43.65万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 43.65万 - 项目类别:
Standard Grant














{{item.name}}会员




